Evaluation of in-stent restenosis in the APPROACH trial (assessment on the prevention of progression by Rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history)

Evaluation of in-stent restenosis in the APPROACH trial (assessment on the prevention of progression by Rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history)

To determine (1) the medium-term effect of rosiglitazone and glipizide on intra-stent neointima hyperplasia, (2) restenosis pattern as assessed by intra-vascular ultrasound (IVUS) and quantitative coronary angiography (QCA) in patients with T2DM and coronary artery disease. A total of 462 patients w...

Full description

Bibliographic Details
Main Authors: García-García, Héctor M., Garg, Scot, Brugaletta, Salvatore, Morocutti, Giorgio, Ratner, Robert E., Kolatkar, Nikheel S., Kravitz, Barbara G., Miller, Diane M., Huang, Chun, Nesto, Richard W., Serruys, Patrick W.
Format: Online
Language:English
Published: Springer Netherlands 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326367/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326367/

Similar Items